Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]
Authors Wang C, Sun T, Huang Y, Sannigrahi S, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D’Andrea P
Received 13 February 2015
Accepted for publication 13 February 2015
Published 30 July 2015 Volume 2015:10(1) Pages 1513—1514
Wang C, Sun T, Huang Y, et al. Int J Chron Obstruct Pulmon Dis. 2015;10:57–68.
The phone number for the corresponding author Chen Wang should be +86 10 8420 6166.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]